Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2025-12-27 @ 9:16 PM
Study NCT ID:
NCT05105295
Status:
UNKNOWN
Last Update Posted:
2021-11-03
First Post:
2021-10-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV Infected
Sponsor:
China National Biotec Group Company Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-22
First Submit QC Date:
None
Study First Post Date:
2021-11-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-22
Last Update Post Date:
2021-11-03
Last Update Post Date Type:
ACTUAL